Accomplishments in 2008 in the management of gastrointestinal neuroendocrine tumors
Affiliations
- PMID: 20011568
- PMCID: PMC2791386
Item in Clipboard
Accomplishments in 2008 in the management of gastrointestinal neuroendocrine tumors
Gastrointest Cancer Res.
2009 Sep.
Abstract
Overview of the Disease ProcessIncidencePrognostic FactorsGeneral Therapy StandardsAccomplishments and Lack of Accomplishments During the YearSomatostatin AnalogsPeptide Receptor-Targeted TherapySelective Internal Radiotherapy (SIRT)CYTOTOXIC THERAPIES: TemozolomideVEGF Pathway InhibitorsmTOR InhibitorsDevelopment of BiomarkersWhat Needs to be Done (Application of the Accomplishments)Controversies and DisagreementsHistologic Classification and Staging of Neuroendocrine TumorsClinical Trial Design and End PointsFuture Directions.
Similar articles
-
Accomplishments in 2007 in the adjuvant treatment of colorectal cancer.Gastrointest Cancer Res. 2008 May;2(3 Suppl):S2-6. Gastrointest Cancer Res. 2008. PMID: 19352464 Free PMC article.
-
Accomplishments in 2007 in the adjuvant treatment of rectal cancer.Gastrointest Cancer Res. 2008 May;2(3 Suppl):S7-S12. Gastrointest Cancer Res. 2008. PMID: 19352473 Free PMC article.
-
Accomplishments in 2007 in the management of hepatobiliary cancers.Gastrointest Cancer Res. 2008 May;2(3 Suppl):S25-31. Gastrointest Cancer Res. 2008. PMID: 19352465 Free PMC article.
-
Neuroendocrine tumors of the gastrointestinal tract and the role of cytotoxic chemotherapy.Expert Rev Anticancer Ther. 2016;16(4):391-401. doi: 10.1586/14737140.2016.1146135. Epub 2016 Feb 17. Expert Rev Anticancer Ther. 2016. PMID: 26808925 Review.
-
Liver-Directed Therapies for Neuroendocrine Neoplasms.Curr Oncol Rep. 2021 Mar 15;23(4):44. doi: 10.1007/s11912-021-01030-0. Curr Oncol Rep. 2021. PMID: 33721122 Review.
Cited by
-
Multidisciplinary management of advanced lung neuroendocrine tumors.J Thorac Dis. 2015 Apr;7(Suppl 2):S163-71. doi: 10.3978/j.issn.2072-1439.2015.04.20. J Thorac Dis. 2015. PMID: 25984363 Free PMC article. Review.
-
Signaling mechanisms in neuroendocrine tumors as targets for therapy.Endocrinol Metab Clin North Am. 2010 Dec;39(4):801-10. doi: 10.1016/j.ecl.2010.08.002. Endocrinol Metab Clin North Am. 2010. PMID: 21095546 Free PMC article. Review.
-
Systemic treatment for lung carcinoids: from bench to bedside.Clin Transl Med. 2019 Jul 4;8(1):22. doi: 10.1186/s40169-019-0238-5. Clin Transl Med. 2019. PMID: 31273555 Free PMC article. Review.
-
Gastrointestinal hormones stimulate growth of Foregut Neuroendocrine Tumors by transactivating the EGF receptor.Biochim Biophys Acta. 2013 Mar;1833(3):573-82. doi: 10.1016/j.bbamcr.2012.11.021. Epub 2012 Dec 4. Biochim Biophys Acta. 2013. PMID: 23220008 Free PMC article.
-
Endoscopic submucosal dissection for foregut neuroendocrine tumors: an initial study.World J Gastroenterol. 2012 Oct 28;18(40):5799-806. doi: 10.3748/wjg.v18.i40.5799. World J Gastroenterol. 2012. PMID: 23155323 Free PMC article.
References
-
- Modlin I, Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer. 1997;79:813–829. - PubMed
-
- Yao JC, Hassan M, Phan A, et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26:3063–3072. - PubMed
-
- Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003;97:934–959. - PubMed
-
- Rindi G, D’Adda T, Froio E, et al. Prognostic factors in gastrointestinal endocrine tumors. Endocr Pathol. 2007;18:145–149. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources